Accelerating Clinical Development with ctDNA Clearance & Multi-Omic Profiling
- Using ctDNA clearance timepoints to optimize dose selection and accelerate internal go or no-go decisions across modalities under Project Optimus
- Expanding beyond mutation profiling through multi-omic approaches to better track resistance, cell surface targets, and combination strategy rationale
- Advancing standardization and regulatory alignment for complex assays throughcollaborative initiatives such as BLOODPAC